Early mortality after chemotherapy as a quality indicator—the leukemia perspective - Top-Institutions - MDSpire

Early mortality after chemotherapy as a quality indicator—the leukemia perspective

  • By

  • Hagop Kantarjian

  • Mary Alma Welch

  • Koji Sasaki

  • December 1, 2023

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematology-Oncology
    • Leukemia
    • Cancer Research

  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology-Oncology
    • Leukemia
    • Stem Cell Transplantation

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hematology-Oncology
    • Leukemia
    • Cancer Therapeutics

  • #4

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematology-Oncology
    • Leukemia
    • Stem Cell Transplantation

  • #5

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Hematology-Oncology
    • Leukemia
    • Clinical Research

Original Source(s)

Early mortality after chemotherapy as a quality indicator—the leukemia perspective

  • by Hagop Kantarjian, Mary Alma Welch, Koji Sasaki

  • December 1, 2023

Related Content

Evaluating the Impact of Pictorial versus Teach-Back Educational Approaches on Self-Efficacy and Quality of Life in Leukemia Patients: A Randomized Controlled Study

The clinical relevance of sole loss of chromosome Y in myeloid neoplasms

Investigating Physical Activity Patterns and Contributing Factors in Pediatric Leukemia Patients Undergoing Chemotherapy: A Cross-Sectional Analysis